Stay up to date on ASPREE news and events
Resources
ASPREE news
Newsletters
Publications
Brochures
Media enquiries
Contact us
ASPREE News
Newsletters
Biannual ASPREE newsletters are sent to ASPREE-XT study participants, providing an easy to read update on research progress, major developments, publications and findings.
Project updates geared towards the medical community are sent to PCPs and practices with patients in the study. Researchers involved in the ASPREE project, or with an interest in the research, are updated on developments and outcomes by the Principal Investigators.
Publications
ASPREE investigators frequently contribute to specialist and broader media articles.
Media
Brenda Kirpach, United States Project Manager
PHONE: 612-873-6905
EMAIL: bkirpach@bermancenter.org
MAILING ADDRESS:
The Berman Center
701 Park Avenue., Suite PPC 4.440
Minneapolis, MN 55415
Contact us
ASPREE and ASPREE-XT US Coordinating Center: Berman Center for Outcomes & Clinical Research
Brenda Kirpach, United States Project Manager
PHONE: 612-873-6905
EMAIL: bkirpach@bermancenter.org
MAILING ADDRESS: The Berman Center
701 Park Avenue., Suite PPC 4.440
Minneapolis, MN 55415
LATEST NEWS
Aspirin and anemia risk in older adults
Low-dose aspirin may increase anemia risk in healthy older adults: study A new study analysing data from the landmark ASPREE trial has found that prolonged daily aspirin use increases the risk of anemia by 20% in some older adults, mostly aged over 70 years (65...
Findings continue to impact aspirin guidelines
U.S. medical expert group latest to cite ASPREE results in guidelines Major findings from the ASPREE trial have been adopted into influential US Preventive Services Taskforce (USPSTF) new medical aspirin guidelines. The USPSTF recently announced a new recommendation...
Blood pressure variability associated with increased risk of dementia, especially in men
New analysis of ASPREE data reveals high long term blood pressure variability (BPV) in older adults, particularly men, is associated with an increased risk of dementia and cognitive decline